First Cited
Last Cited

Articles citing This Document (Page 1 of 5)

Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma2022
Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting2022
Resolution of the expert council “Modern options for the treatment of urothelial cancer”2022
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis2022
Urethral Cancer After Urethroplasty: A Case Report and Review of the Literature2022
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitorsUrologic Oncology: Seminars and Original Investigations2022
Reply to: Comments on "Neoadjuvant/Induction Combination Immunotherapy versus Combination Platinum‐based Chemotherapy for Locally Advanced (Stage III) Urothelial Cancer."International Journal of Cancer
The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial CarcinomaBiomedicines2022
PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary MalignanciesCancers2022
Insights on recent innovations in bladder cancer immunotherapyCancer Cytopathology
Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatmentInternational Journal of Urology
Survival after Neoadjuvant/Induction Combination Immunotherapy versus Combination Platinum‐based Chemotherapy for Locally Advanced (Stage III ) Urothelial CancerInternational Journal of Cancer
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring.Cancer2022
Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients With Large Unresectable Hepatocellular Carcinoma.Frontiers in Pharmacology2022
Head-to-Head Comparison of the Expression Differences of NECTIN-4, TROP-2, and HER2 in Urothelial Carcinoma and Its Histologic Variants.Frontiers in Oncology2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.Nature Communications2022
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer.Cancers2022
Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care?Drugs and Aging2022
Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.International Journal of Urology2021
Efficacy of Surgery on the Primary Tumour in Patients with Metastatic Bladder Cancer: A Comprehensive ReviewBladder Cancer2022
Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeons.Urologic Oncology: Seminars and Original Investigations2022
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day.Biomedicines2022
Digital ischaemia and necrosis from oxaliplatin.BMJ Case Reports2022
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond.Cells2022
Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer2022
Impact of FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.Clinical Genitourinary Cancer2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis.European Urology2022
Re: Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.European Urology2022
Management of Patients With Advanced Urothelial Carcinoma in an Evolving Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line Therapies.Clinical Genitourinary Cancer2021
A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.Advances in Radiation Oncology2022
Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled TrialsEuropean Urology2021
Upper Tract Urothelial Carcinoma2021
Intravesical Therapy for Non-muscle Invasive Urothelial Carcinoma2021
Medical Oncology2008
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.Clinical Genitourinary Cancer2021
Latest progress in molecular biology and treatment in genitourinary tumoursClinical and Translational Oncology2020
Validity of using cancer registry data for comparative effectiveness research
Metastatic Nodal Pattern: Is There a Role for Paraaortic Lymph Node Dissection2018
Integrating chemotherapy and radiotherapy for bladder cancer
Impact of health services on compliance and outcomes
The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract2015
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial CarcinomaClinical Genitourinary Cancer2021
Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness studyBJU International2021
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United StatesAdvances in Therapy2021
Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017Urology Annals2018
Prognostic role of delay before radical cystectomy: retrospective analysis of a single-centre cohort with 376 patientsMinerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology2018
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)ClinicoEconomics and Outcomes Research2020
Incidence of upper tract urothelial carcinoma in SpainActas Urológicas Españolas2020
Antibody-Drug Conjugates in Urothelial CarcinomasCurrent Oncology Reports2020
Treatment Overview2017